» Articles » PMID: 39060438

High Throughput Spatial Immune Mapping Reveals an Innate Immune Scar in Post-COVID-19 Brains

Abstract

The underlying pathogenesis of neurological sequelae in post-COVID-19 patients remains unclear. Here, we used multidimensional spatial immune phenotyping and machine learning methods on brains from initial COVID-19 survivors to identify the biological correlate associated with previous SARS-CoV-2 challenge. Compared to healthy controls, individuals with post-COVID-19 revealed a high percentage of TMEM119P2RY12CD68Iba1HLA-DRCD11cSCAMP2 microglia assembled in prototypical cellular nodules. In contrast to acute SARS-CoV-2 cases, the frequency of CD8 parenchymal T cells was reduced, suggesting an immune shift toward innate immune activation that may contribute to neurological alterations in post-COVID-19 patients.

References
1.
Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J . Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2022; 29(1):226-235. PMC: 9873564. DOI: 10.1038/s41591-022-02116-3. View

2.
Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

3.
Soriano J, Murthy S, Marshall J, Relan P, Diaz J . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021; 22(4):e102-e107. PMC: 8691845. DOI: 10.1016/S1473-3099(21)00703-9. View

4.
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604(7907):697-707. PMC: 9046077. DOI: 10.1038/s41586-022-04569-5. View

5.
Radke J, Meinhardt J, Aschman T, Chua R, Farztdinov V, Lukassen S . Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19. Nat Neurosci. 2024; 27(3):409-420. DOI: 10.1038/s41593-024-01573-y. View